|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-6-25
|
|
pubmed:abstractText |
Although the pharmodynamic properties of the thiazolidinedione (TZD) insulin-sensitizing agents in the treatment of type 2 diabetes are well established, there are no studies comparing the pharmacoefficacy of these drugs in different ethnic groups. The aim of this pilot, prospective study was to examine the hypothesis that the efficacy of TZDs may vary depending on ethnicity. This aim was achieved by comparing the effects of 6-months treatment with pioglitazone (45 mg/day) on glucose control and metabolic and cardiovascular risk factors in Caucasian and Maori-Polynesian patients with poorly controlled type 2 diabetes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1462-8902
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
540-7
|
|
pubmed:dateRevised |
2009-11-3
|
|
pubmed:meshHeading |
pubmed-meshheading:17587396-Adiponectin,
pubmed-meshheading:17587396-Adult,
pubmed-meshheading:17587396-Aged,
pubmed-meshheading:17587396-Blood Glucose,
pubmed-meshheading:17587396-Body Mass Index,
pubmed-meshheading:17587396-Diabetes Mellitus, Type 2,
pubmed-meshheading:17587396-European Continental Ancestry Group,
pubmed-meshheading:17587396-Female,
pubmed-meshheading:17587396-Hemoglobin A, Glycosylated,
pubmed-meshheading:17587396-Humans,
pubmed-meshheading:17587396-Hypoglycemic Agents,
pubmed-meshheading:17587396-Male,
pubmed-meshheading:17587396-Middle Aged,
pubmed-meshheading:17587396-New Zealand,
pubmed-meshheading:17587396-Polynesia,
pubmed-meshheading:17587396-Reproducibility of Results,
pubmed-meshheading:17587396-Thiazolidinediones,
pubmed-meshheading:17587396-Triglycerides
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Comparative study on the efficacy of pioglitazone in Caucasian and Maori-Polynesian patients with poorly controlled type 2 diabetes.
|
|
pubmed:affiliation |
Lipid and Diabetes Research Group, Christchurch Hospital, Christchurch, New Zealand. brett.shand@cdhb.govt.nz
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
